Loading...

FITC anti-mouse CD45 Antibody

Pricing & Availability
Clone
30-F11 (See other available formats)
Regulatory Status
RUO
Other Names
T200, Ly-5, LCA
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
30-f11
C57BL/6 splenocytes stained with 30-F11 FITC
  • 30-f11
    C57BL/6 splenocytes stained with 30-F11 FITC
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
103107 50 µg 29€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103108 500 µg 84€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45 is a 180-240 kD glycoprotein also known as the leukocyte common antigen (LCA), T200, or Ly-5. It is a member of the protein tyrosine phosphatase (PTP) family, expressed on all hematopoietic cells except mature erythrocytes and platelets. There are different isoforms of CD45 that arise from variable splicing of exons 4, 5, and 6, which encode A, B, and C determinants, respectively. CD45 plays a key role in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation state of the cell as well as cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone 30-F11 reacts with all isoforms and both CD45.1 and CD45.2 alloantigens of CD45.

Additional reported applications (for relevant formats) include: immunoprecipitation3, complement-dependent cytotoxicity1,5, immunohistochemistry (acetone-fixed frozen sections, zinc-fixed paraffin-embedded sections and formalin-fixed paraffin-embedded sections)4,6, Western blotting7, and spatial biology (IBEX)10,11. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103163 and 103164).

Application References

(PubMed link indicates BioLegend citation)
  1. Podd BS, et al. 2006. J. Immunol. 176:6532. (FC, CMCD) PubMed
  2. Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC)
  3. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IP)
  4. Simon DI, et al. 2000. J. Clin. Invest. 105:293. (IHC)
  5. Seaman WE. 1983. J. Immunol. 130:1713. (CMCD)
  6. Cornet A, et al. 2001. P. Natl. Acad. Sci. USA 98:13306. (IHC)
  7. Tsuboi S and Fukuda M. 1998. J. Biol. Chem. 273:30680. (WB) PubMed
  8. Liu F, et al. 2012. Blood. 119:3295. PubMed
  9. Pelletier AN, et al. 2012. J. Immunol. 188:5561. PubMed
  10. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  11. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. J Gautam, X Zhang, Y Yao 2016. Sci Rep. 6:36450. PubMed
  2. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  3. Xu X, et al. 2020. Chin Med. 15:33. PubMed
  4. Shakya S, et al. 2020. MethodsX. 7:101027. PubMed
  5. Johnson DC, et al. 2018. Nat Med. 24:1151. PubMed
  6. Sefik E, et al. 2022. Nature. 606:585. PubMed
  7. Leinroth AP, et al. 2022. Cell Rep. 39:110785. PubMed
  8. Doughty D, et al. 2022. Exp Biol Med (Maywood). 247:1433. PubMed
  9. Du M, et al. 2022. Cancer Sci. 113:2974. PubMed
  10. Grégoire C, et al. 2022. Immunity. 55:1216. PubMed
  11. Tao X, et al. 2022. EMBO J. 41:e110439. PubMed
  12. Blanco LP, et al. 2022. Arthritis Rheumatol. 74:1971. PubMed
  13. Li X, et al. 2022. Cell Mol Gastroenterol Hepatol. 14:1077. PubMed
  14. Hindy G, et al. 2022. J Clin Invest. 132: . PubMed
  15. Roy IM, et al. 2022. iScience. 25:105171. PubMed
  16. Mendivil-Perez M, et al. 2022. Med Oncol. 40:15. PubMed
  17. Chen X, et al. 2022. J Extracell Vesicles. 11:e12279. PubMed
  18. Zheng Z, et al. 2022. Cells. 11: . PubMed
  19. Voit RA, et al. 2023. Nat Immunol. 24:69. PubMed
  20. Varshney R, et al. 2023. iScience. 26:105750. PubMed
  21. Cheng P, et al. 2023. Pharmacol Res. 188:106643. PubMed
  22. Jin SM, et al. 2023. Nat Nanotechnol. :. PubMed
  23. Chen L, et al. 2023. Bioeng Transl Med. 8:e10377. PubMed
  24. Stravokefalou V, et al. 2023. Front Immunol. 13:1014802. PubMed
  25. Zhao Y, et al. 2023. Sci Adv. 9:eabo1360. PubMed
  26. Liu X, et al. 2022. Pain. 163:508. PubMed
  27. González H, et al. 2022. Cell. 185:729. PubMed
  28. Mecklenburg J, et al. 2022. Brain Behav Immun. 101:246. PubMed
  29. Na E, et al. 2022. Am J Physiol Lung Cell Mol Physiol. 322:L550. PubMed
  30. Ma Y, et al. 2022. Am J Physiol Heart Circ Physiol. 322:H622. PubMed
  31. Ajay AK, et al. 2022. Cell Rep. 38:110473. PubMed
  32. Mise Y, et al. 2022. Carcinogenesis. 43:647. PubMed
  33. Pfeifhofer-Obermair C, et al. 2022. Bio Protoc. 12:e4378. PubMed
  34. Hanuscheck N, et al. 2022. J Exp Med. 219:. PubMed
  35. Klawitter M, et al. 2022. Int J Mol Sci. 23:. PubMed
  36. Zheng Y, et al. 2022. Proc Natl Acad Sci U S A. 119:e2121077119. PubMed
  37. Bowley TY, et al. 2022. Cancer Res Commun. 2:1436. PubMed
  38. Chen Y, et al. 2022. Am J Cancer Res. 12:5286. PubMed
  39. Zhang Y, et al. 2023. Invest Ophthalmol Vis Sci. 64:1. PubMed
  40. Sparbier CE, et al. 2023. Nat Cell Biol. 25:258. PubMed
  41. Li Y, et al. 2023. Adv Mater. 35:e2208923. PubMed
  42. Li M, et al. 2023. Front Immunol. 14:1087923. PubMed
  43. Chen H, et al. 2023. Nat Commun. 14:941. PubMed
  44. Ferriz M, et al. 2023. STAR Protoc. 4:102079. PubMed
  45. Volkova MV, et al. 2023. Int J Mol Sci. 24:. PubMed
  46. Solier S, et al. 2023. Int J Mol Sci. 24:. PubMed
  47. Li L, et al. 2023. iScience. 26:106095. PubMed
  48. Cheong LY, et al. 2023. Nat Commun. 14:1213. PubMed
  49. Xu H, et al. 2023. Acta Pharm Sin B. 13:678. PubMed
  50. Kozlovski S, et al. 2023. Front Immunol. 13:1041552. PubMed
  51. Rege SV, et al. 2023. Commun Biol. 6:292. PubMed
  52. Wang Y, et al. 2023. J Nanobiotechnology. 21:109. PubMed
  53. Zhang X, et al. 2023. Front Immunol. 14:1116749. PubMed
  54. Kim BH, et al. 2023. Sci Rep. 13:6577. PubMed
  55. Li T, et al. 2023. Nat Commun. 14:2498. PubMed
  56. Kase N, et al. 2023. Front Cell Dev Biol. 11:1022081. PubMed
  57. Huang T, et al. 2023. Cell Death Dis. 14:354. PubMed
  58. Guo X, et al. 2023. Mol Immunol. 160:32. PubMed
  59. Wang X, et al. 2023. Nature. 618:808. PubMed
  60. Akasaka H, et al. 2023. JCI Insight. 8:. PubMed
  61. Nederlof R, et al. 2022. Front Immunol. 13:908023. PubMed
  62. Kataru RP, et al. 2021. Sci Signal. 14:. PubMed
  63. Li Z, et al. 2022. Nat Commun. 13:1845. PubMed
  64. Li Y, et al. 2020. Nat Commun. 2.350694444. PubMed
  65. Gabitova-Cornell L, et al. 2020. Cancer Cell. 38(4):567-583.e11. PubMed
  66. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  67. Hutton C, et al. 2021. Cancer Cell. 39:1227. PubMed
  68. Duquesne, P., Aoun, C., et al. 2025. Sci Adv. 11(42),eadx7672. PubMed
  69. Zhang, X., Ji, Z., et al. 2025. Mater Today Bio. 34(0),102166. PubMed
  70. Huang Z et al. 2017. Cell metabolism. 26(3):493-508 . PubMed
  71. McGill BE et al. 2018. The Journal of Neuroscience. 38(1):200-219 . PubMed
  72. Hofmann I, et al. 2022. J Pharmacol Exp Ther. Online ahead of print. PubMed
  73. Hulsebus HJ, et al. 2022. Front Immunol. 13:884719. PubMed
  74. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  75. El-Hindi K, et al. 2022. Int J Mol Sci. 23:. PubMed
  76. Qi Z, et al. 2022. Nat Commun. 13:182. PubMed
  77. Ma J, et al. 2020. Adv Sci (Weinh). 7:2000609. PubMed
  78. Sharma GP, et al. 2021. PLoS One. 16:e0259042. PubMed
  79. Abdala-Valencia H, et al. 2014. Am J Physiol Lung Cell Mol Physiol. 307:482. PubMed
  80. Zhu H, et al. 2018. Elife. 7:. PubMed
  81. Bauer KM, et al. 2022. JCI Insight. 7:. PubMed
  82. Sepe JJ, et al. 2022. JACC Basic Transl Sci. 7:915. PubMed
  83. Prado C, et al. 2021. J Neuroinflammation. 18:292. PubMed
  84. Wang M, et al. 2022. Theranostics. 12:4513. PubMed
  85. Adachi Y, et al. 2022. Nat Commun. 13:5117. PubMed
  86. Rodriguez-García A, et al. 2021. Nat Commun. 12:877. PubMed
  87. Tcheng M, et al. 2021. Blood. 137:3518. PubMed
  88. Shao Y, et al. 2019. Diabetes. 68:2131. PubMed
  89. Lee AK, et al. 2020. Radiat Res. 193:305. PubMed
  90. Choi H et al. 2019. Cell Rep. 27(3):806-819 . PubMed
  91. Agelidis A, et al. 2019. Front Immunol. 10:500. PubMed
  92. Neumann AM et al. 2017. PloS one. 12(11):e0187330 . PubMed
  93. Pan D, et al. 2022. Cancer Res. 82:2748. PubMed
  94. Rao E, et al. 2021. Sci Immunol. 6:. PubMed
  95. Saito S, et al. 2020. Nutrients. 12:. PubMed
  96. Liu X, et al. 2020. Nature. . PubMed
  97. Liang W, et al. 2020. Nat Commun. 4.563888889. PubMed
  98. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  99. Ohigashi I, et al. 2020. Cell Reports. 29(9):2901-2916.e6.. PubMed
  100. Zhang Q, et al. 2019. PLoS Biol. 17:e3000330. PubMed
  101. Ihara S, et al. 2022. PLoS Negl Trop Dis. 16:e0010323. PubMed
  102. Talma N, et al. 2021. Aging Cell. 20:e13450. PubMed
  103. Zhao G, et al. 2020. Sci Adv. 6:00. PubMed
  104. Evren E, et al. 2020. Immunity. 54(2):259-275.e7. PubMed
  105. Wosczyna MN, et al. 2021. Cell Stem Cell. 28(7):1323-1334.e8. PubMed
  106. Pan H, et al. 2020. Mol Psychiatry. . PubMed
  107. Wang X, et al. 2021. Front Cell Dev Biol. 632805:9. PubMed
  108. Zhang C, et al. 2020. Cell Metabolism. 31(1):148-161.e5.. PubMed
  109. Lu Y, et al. 2020. Cell. 180(6):1081-1097. PubMed
  110. Meixiong J et al. 2019. Immunity. 50(5):1163-1171 . PubMed
  111. Xiao X, et al. 2019. Cell Discov. 5:2. PubMed
  112. Dai B, et al. 2022. Theranostics. 12:7603. PubMed
  113. Francian A, et al. 2021. J Drug Target. 29:754. PubMed
  114. Johansen AZ, et al. 2022. Pharmaceutics. 14:. PubMed
  115. Rolfes S, et al. 2020. Neurobiol Dis. 144:105024. PubMed
  116. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  117. Han C, et al. 2021. Cell Reports. 34(6):108706. PubMed
  118. Davidson S, et al. 2020. Cell Reports. 31(7):107628. PubMed
  119. Emgård J, et al. 2018. Immunity. 143:419. PubMed
  120. Parada-Kusz M, et al. 2018. Dis Model Mech. 11:. PubMed
  121. Feng Y, et al. 2018. Kidney Dis (Basel). 4:95. PubMed
  122. Wosczyna MN et al. 2019. Cell Rep. 27(7):2029-2035 . PubMed
  123. Plein A, et al. 2018. Nature. 562:223. PubMed
  124. Kobayashi S, et al. 2019. J Immunol. 203:1447. PubMed
  125. Green DP, et al. 2019. Neuron. 101:412. PubMed
  126. Dane EL, et al. 2022. Nat Mater. 21:710. PubMed
  127. Yao L, et al. 2021. J Bone Miner Res. 36:1159. PubMed
  128. Koujah L, et al. 2021. Ocul Surf. 21:238. PubMed
  129. Kumari A, et al. 2022. Sci Rep. 12:15273. PubMed
  130. Li P, et al. 2021. Nat Immunol. 22:1107. PubMed
  131. Zhang X, et al. 2022. Cells. 11:. PubMed
  132. Kucinski I, et al. 2020. EMBO J. :e104983. PubMed
  133. Müller A, et al. 2020. J Clin Invest. 5765:130. PubMed
  134. Liang Z, et al. 2020. Pain. 161:2089. PubMed
  135. Zhang W, et al. 2021. Cell Prolif. 54:e13058. PubMed
  136. Gui J, et al. 2020. Nat Cancer. 1:603. PubMed
  137. Hore ZL, et al. 2021. Wellcome Open Res. 6:68. PubMed
  138. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  139. Barman PK, et al. 2019. J Immunol. 202:2720. PubMed
  140. Lim D, et al. 2018. Front Physiol. 9:47. PubMed
  141. Zein HS, et al. 2022. Sci Rep. 12:4834. PubMed
  142. Luo W, et al. 2022. Front Immunol. 13:816761. PubMed
  143. Kusuyama J, et al. 2021. Cell Metabolism. 33(5):939-956.e8. PubMed
  144. Zhang K, et al. 2014. PLoS Pathog. 10:1004385. PubMed
  145. Mencarelli A, et al. 2016. Sci Rep. 6:30802. PubMed
  146. Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed
  147. Cervera–Carrascon V, et al. 2020. Oncoimmunology. 9:1761229. PubMed
  148. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  149. Wang ECE, et al. 2019. Cell Stem Cell. 24:654. PubMed
  150. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  151. Gañán-Gómez I, et al. 2022. Nat Med. . PubMed
  152. Chin AL, et al. 2021. Nat Commun. 12:5138. PubMed
  153. Hu J, et al. 2020. Theranostics. 7.154166667. PubMed
  154. Li J, et al. 2020. Elife. 9:00. PubMed
  155. Rosa JM, et al. 2021. British Journal of Pharmacology. . PubMed
  156. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  157. Morimoto A, et al. 2021. Nat Commun. 12:2136. PubMed
  158. Poillet-Perez L, et al. 2020. Nat Cancer. 1:923. PubMed
  159. Wan X, et al. 2018. Nature. 560:107. PubMed
  160. Al–Zaher AA, et al. 2018. Mol Ther Oncolytics. 0.376388889. PubMed
  161. Hepler C et al. 2018. eLife. 7 pii: e39636. PubMed
  162. Goldfarb Y, et al. 2021. J Exp Med. 218:. PubMed
  163. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  164. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  165. Brigas HC, et al. 2021. Cell Reports. 36(9):109574. PubMed
  166. Zhu H, et al. 2021. Cell Metabolism. :. PubMed
  167. Nguyen PT, et al. 2020. Cell. 182(2):388-403.e15. PubMed
  168. Liu CY, et al. 2020. Cell Rep. 33:108275. PubMed
  169. Burr ML, et al. 2019. Cancer Cell. 36:385. PubMed
  170. Wang F, et al. 2019. MAbs. 12:1685350. PubMed
  171. Ji DX, et al. 2019. Nat Microbiol. 1.644444444. PubMed
  172. Liu S, et al. 2020. Cell Host & Microbe. 26(6):779-794.e8.. PubMed
  173. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  174. Cai Y, et al. 2019. Cell Rep. 27:3034. PubMed
  175. Crowell PD et al. 2019. Cell Rep. 28(6):1499-1510 . PubMed
  176. Maetzig T, et al. 2017. Mol Ther. 25:606. PubMed
  177. Sefik E, et al. 2021. Nat Biotechnol. . PubMed
  178. Watanabe Y, et al. 2020. J Biol Chem. 295:17632. PubMed
  179. Engler AE, et al. 2020. Cell Reports. 33(13):108553. PubMed
  180. Ruan C, et al. 2020. Brain Behav Immun. 83:180. PubMed
  181. Galle-Treger L, et al. 2016. Nat Commun. 7:13202. PubMed
  182. Coronel MM, et al. 2020. Sci Adv. 6:eaba5573. PubMed
  183. Pundir P, et al. 2020. Cell Host & Microbe. 26(1):114-122. PubMed
  184. Gastelum‐Aviña P et al. 2016. Journal of immunological methods. 438:42-50 . PubMed
  185. Zhou J, et al. 2019. Nat Commun. 10:2427. PubMed
  186. Yu X, et al. 2019. Nat Commun. 10:574. PubMed
  187. Su S et al. 2018. Cell. 175(2):442-457 . PubMed
  188. Milner MT, et al. 2022. STAR Protoc. 3:101295. PubMed
  189. Zhang X, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  190. Xiao L, et al. 2021. Clin Cancer Res. 27:4338. PubMed
  191. Kotas ME, et al. 2022. JCI Insight. :. PubMed
  192. Rashid MH, et al. 2021. Oncol Rep. 45:1171. PubMed
  193. Jiang Y, et al. 2021. Cell Death Differ. 28:3009. PubMed
  194. Agelidis A, et al. 2021. JCI Insight. 6: . PubMed
  195. Monaghan KL, et al. 2020. J Vis Exp. . PubMed
  196. Yamakawa D, et al. 2021. Cell Reports. 34(10):108817. PubMed
  197. Ito K, et al. 2014. Proc Natl Acad Sci U S A. 111:3080. PubMed
  198. Saunders L, et al. 2015. Sci Transl Med. 7: 302ra136. PubMed
  199. Wang Z et al. 2018. Immunity. 49(1):80-92 . PubMed
  200. Sarvi S et al. 2018. Cell chemical biology. 25(12):1456-1469 . PubMed
  201. Sirvinskas D, et al. 2022. iScience. 25:104202. PubMed
  202. Minhas PS, et al. 2021. Nature. 590:122. PubMed
  203. Zhang X, et al. 2021. Mol Cancer Res. 19:1076. PubMed
  204. Liu S, et al. 2022. J Neuroinflammation. 19:35. PubMed
  205. Xiao Y, et al. 2022. Nat Commun. 13:758. PubMed
  206. Ali S, et al. 2021. PLoS One. 16:e0246646. PubMed
  207. Yang Z, et al. 2021. Nat Commun. 12:4852. PubMed
  208. Long JT, et al. 2022. Elife. 11:. PubMed
  209. Bravo-Caparrós I, et al. 2020. FASEB J. 34:5951. PubMed
  210. Zhang P, et al. 2022. Nat Commun. 13:1588. PubMed
  211. Jiang Q, et al. 2020. JCI Insight. 5:00. PubMed
  212. Hasegawa T, et al. 2020. Sci Rep. 10:13480. PubMed
  213. Johnson DC, et al. 2020. Cell Death Dis. 0.894444444. PubMed
  214. Li CM, et al. 2020. Cell Reports. 33(13):108566. PubMed
  215. Zhang L, et al. 2021. iScience. 24(9):102942. PubMed
  216. Hu Y, et al. 2021. Cell Death Dis. 12:743. PubMed
  217. Qi F, et al. 2019. Front Microbiol. 2.140277778. PubMed
  218. Yu JM, et al. 2019. Nat Commun. 4.388888889. PubMed
  219. Li Z, et al. 2022. Nat Commun. 13:6321. PubMed
  220. Hou Y, et al. 2021. Sci Transl Med. 13:. PubMed
  221. Xu G, et al. 2022. Front Pharmacol. 13:896601. PubMed
  222. Zhou J, et al. 2022. Int J Oncol. 61: . PubMed
  223. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  224. Song J, et al. 2021. Am J Physiol Heart Circ Physiol. 320:H323. PubMed
  225. Zeis P, et al. 2020. Immunity. 53:775. PubMed
  226. Ben-Yehuda H, et al. 2021. Mol Neurodegener. 16:39. PubMed
  227. Kim H, et al. 2020. Biomed Rep. 0.589583333. PubMed
  228. Ovadya Y, et al. 2018. Nat Commun. 9:5435. PubMed
  229. Tomimatsu M, et al. 2022. Sci Rep. 12:16656. PubMed
  230. Ferrer-Font L, et al. 2020. Elife. 9:. PubMed
  231. Sakai H, et al. 2022. iScience. 25:103928. PubMed
  232. Walker MT, et al. 2021. Front. Allergy. 2:. PubMed
  233. Kataru RP, et al. 2022. Front Aging. 3:864860. PubMed
  234. Pan Y, et al. 2021. Br J Pharmacol. 178:4907. PubMed
  235. Zheng B, et al. 2021. Bioact Mater. 6:3879. PubMed
  236. Chen M, et al. 2019. Cell Stem Cell. 25:501. PubMed
  237. Sema Kurtulus et al. 2018. Immunity. 50(1):181-194 . PubMed
  238. Liu L et al. 2018. Cell stem cell. 23(4):544-556 . PubMed
  239. Zhao N, et al. 2018. J Clin Invest. 26:84. PubMed
  240. Hameed H, et al. 2022. Int J Mol Sci. 23:. PubMed
  241. Ding R, et al. 2022. J Neuroinflammation. 19:137. PubMed
  242. Liu R, et al. 2020. Eur J Vasc Endovasc Surg. 60:254. PubMed
  243. Fan ZP, et al. 2021. Front Immunol. 12:743354. PubMed
  244. Okada R, et al. 2021. EBioMedicine. 67:103345. PubMed
  245. Cerina M, et al. 2017. Brain Behav Immun. 59:103-117. PubMed
  246. Chao Y, et al. 2020. Sci Adv. 6:eaaz4204. PubMed
  247. Kataru RP, et al. 2019. Cancer Immunol Res. 7:1345. PubMed
  248. Krivtsov AV, et al. 2020. Cancer Cell. 36(6):660-673.e11.. PubMed
  249. Hu X, et al. 2020. Neoplasia. 1.290972222. PubMed
  250. Ding L et al. 2018. Cell reports. 25(11):2972-2980 . PubMed
  251. Hao T, et al. 2019. Nat Commun. 10:3665. PubMed
  252. Zegarra‐Ruiz DF et al. 2018. Cell host & microbe. 25(1):113-127 . PubMed
  253. Banskota S, et al. 2021. Inflamm Bowel Dis. 27:914. PubMed
  254. Ruan Y, et al. 2022. Exp Ther Med. 23:47. PubMed
  255. Wang R, et al. 2022. J Immunother Cancer. 10:. PubMed
  256. Liao X, et al. 2022. JCI Insight. 7:. PubMed
  257. Kelley WJ, et al. 2022. JCI Insight. 7: . PubMed
  258. Simoes Eugénio M, et al. 2020. Cancers (Basel). 12:00. PubMed
  259. Chen L, et al. 2021. Theranostics. 11:6668. PubMed
  260. Sugita Y, et al. 2021. Oncol Rep. 45:. PubMed
  261. Tr änkner D, et al. 2019. Cell Rep. 29:791. PubMed
  262. Lee C, et al. 2020. Front Immunol. 11:77. PubMed
  263. Eckert EC, et al. 2020. Mol Ther Oncolytics. 0.710416667. PubMed
  264. Poillet–Perez L, et al. 2018. Nature. 563:569. PubMed
  265. Padhye A, et al. 2019. Sci Rep. 9:4819. PubMed
  266. Zhou Y, et al. 2022. Theranostics. 12:5488. PubMed
  267. Sheng D, et al. 2022. J Immunother Cancer. 10:. PubMed
  268. El-Obeid A, et al. 2021. Exp Ther Med. 22:1081. PubMed
  269. Sharma R, et al. 2021. J Neuroinflammation. 72:18. PubMed
  270. Watanabe Y, et al. 2020. J Biol Chem. . PubMed
  271. Sheng J, et al. 2021. eLife. 10:00. PubMed
  272. Shao Y, et al. 2019. Stem Cells. 37:1331. PubMed
  273. Krotova K, et al. 2019. Mol Ther Oncolytics. 15:166. PubMed
  274. Gupta R, et al. 2020. Cell Stem Cell. 26:527. PubMed
  275. Le TM et al. 2018. Journal of neurochemistry. 145(2):139-153 . PubMed
  276. Lee EKS, et al. 2018. Cell Host Microbe. 23:121. PubMed
  277. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  278. Li M, et al. 2020. Nat Commun. 4051:11. PubMed
  279. Ma Y, et al. 2020. Front Immunol. 11:586685. PubMed
  280. Pessoa Rodrigues C, et al. 2020. Sci Adv. 6:eaaz4815. PubMed
  281. Guarnerio J, et al. 2018. Nat Commun. 9:66. PubMed
  282. Wolf Y, et al. 2019. Cell. 179:219. PubMed
  283. Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed
  284. Wang H, et al. 2022. J Cancer. 13:2126. PubMed
  285. Zhang SJ, et al. 2021. Adv Sci (Weinh). 8:2003410. PubMed
  286. Zhang L, et al. 2021. Mol Ther. 29:744. PubMed
  287. Andreata F, et al. 2021. STAR Protoc. 2:100831. PubMed
  288. Ichinose M, et al. 2021. Sci Rep. 7200:11. PubMed
  289. Zhang B, et al. 2021. Front Neurol. 607370:12. PubMed
  290. Dingler FA, et al. 2020. Mol Cell. . PubMed
  291. Wan Y, et al. 2020. Cell Rep. 33:108346. PubMed
  292. Badgujar DC, et al. 2020. PLoS Pathog. 16:e1009016. PubMed
RRID
AB_312972 (BioLegend Cat. No. 103107)
AB_312973 (BioLegend Cat. No. 103108)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4, TCR, CD22, Thy-1
Cell Type
B cells, Dendritic cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID
UniProt
View information about CD45 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD45 Reagents Request Custom Conjugation
Description Clone Applications
PE anti-mouse CD45 30-F11 FC
PE/Cyanine5 anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 30-F11 FC,IHC-F,CyTOF®,IP,CMCD,IHC,WB
PE/Cyanine7 anti-mouse CD45 30-F11 FC
PE/Dazzle™ 594 anti-mouse CD45 30-F11 FC
Brilliant Violet 711™ anti-mouse CD45 30-F11 FC
Brilliant Violet 785™ anti-mouse CD45 30-F11 FC
Brilliant Violet 650™ anti-mouse CD45 30-F11 FC
APC/Fire™ 750 anti-mouse CD45 30-F11 FC
Brilliant Violet 750™ anti-mouse CD45 30-F11 FC
TotalSeq™-A0096 anti-mouse CD45 30-F11 PG
TotalSeq™-B0096 anti-mouse CD45 30-F11 PG
Ultra-LEAF™ Purified anti-mouse CD45 30-F11 FC,CyTOF®,IP,CMCD,IHC,WB
Spark Blue™ 550 anti-mouse CD45 30-F11 FC
Spark NIR™ 685 anti-mouse CD45 30-F11 FC
TotalSeq™-C0096 anti-mouse CD45 30-F11 PG
Spark YG™ 570 anti-mouse CD45 30-F11 IHC-F
PE/Fire™ 640 anti-mouse CD45 30-F11 FC
APC/Fire™ 810 anti-mouse CD45 30-F11 FC
PE/Fire™ 700 anti-mouse CD45 30-F11 FC
APC anti-mouse CD45 30-F11 FC
Biotin anti-mouse CD45 30-F11 FC
FITC anti-mouse CD45 30-F11 FC
APC/Cyanine7 anti-mouse CD45 30-F11 FC
Alexa Fluor® 488 anti-mouse CD45 30-F11 FC,SB
Alexa Fluor® 647 anti-mouse CD45 30-F11 FC,ICC,IHC,3D IHC,SB
Pacific Blue™ anti-mouse CD45 30-F11 FC
Alexa Fluor® 700 anti-mouse CD45 30-F11 FC,SB
PerCP/Cyanine5.5 anti-mouse CD45 30-F11 FC
PerCP anti-mouse CD45 30-F11 FC
Alexa Fluor® 594 anti-mouse CD45 30-F11 IHC-F,FC,3D IHC
Brilliant Violet 421™ anti-mouse CD45 30-F11 FC,SB
Brilliant Violet 570™ anti-mouse CD45 30-F11 FC
Brilliant Violet 510™ anti-mouse CD45 30-F11 FC
Brilliant Violet 605™ anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 (Maxpar® Ready) 30-F11 FC,CyTOF®
Spark Violet™ 538 anti-mouse CD45 30-F11 FC
Spark YG™ 593 anti-mouse CD45 30-F11 FC
Spark Blue™ 574 anti-mouse CD45 Antibody 30-F11 FC
Spark Blue™ 515 anti-mouse CD45 30-F11 FC
Spark UV™ 387 anti-mouse CD45 30-F11 FC
PE/Fire™ 810 anti-mouse CD45 30-F11 FC
Spark PLUS UV395™ anti-mouse CD45 30-F11 FC
Spark Red™ 718 anti-mouse CD45 30-F11 FC
Spark YG™ 581 anti-mouse CD45 (Flexi-Fluor™) 30-F11 FC
Spark PLUS V475™ anti-mouse CD45 Antibody 30-F11 FC
StarBright UltraViolet 740 anti-mouse CD45 30-F11 FC
PE/Fire™ 744 anti-mouse CD45 30-F11 FC
StarBright UltraViolet 665 anti-mouse CD45 30-F11 FC
Go To Top Version: 2    Revision Date: 05.14.2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account